JPWO2021243172A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021243172A5 JPWO2021243172A5 JP2022571787A JP2022571787A JPWO2021243172A5 JP WO2021243172 A5 JPWO2021243172 A5 JP WO2021243172A5 JP 2022571787 A JP2022571787 A JP 2022571787A JP 2022571787 A JP2022571787 A JP 2022571787A JP WO2021243172 A5 JPWO2021243172 A5 JP WO2021243172A5
- Authority
- JP
- Japan
- Prior art keywords
- rna replicon
- recombinant rna
- item
- cancer
- coding region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063032000P | 2020-05-29 | 2020-05-29 | |
| US63/032,000 | 2020-05-29 | ||
| PCT/US2021/034787 WO2021243172A1 (en) | 2020-05-29 | 2021-05-28 | Encapsulated rna replicons and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023528300A JP2023528300A (ja) | 2023-07-04 |
| JPWO2021243172A5 true JPWO2021243172A5 (https=) | 2024-06-04 |
| JP2023528300A5 JP2023528300A5 (https=) | 2024-06-04 |
Family
ID=78722848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022571787A Withdrawn JP2023528300A (ja) | 2020-05-29 | 2021-05-28 | 封入されたrnaレプリコンおよび使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230416308A1 (https=) |
| EP (1) | EP4157456A4 (https=) |
| JP (1) | JP2023528300A (https=) |
| KR (1) | KR20230019450A (https=) |
| CN (1) | CN115666722A (https=) |
| AU (1) | AU2021281357A1 (https=) |
| CA (1) | CA3180557A1 (https=) |
| WO (1) | WO2021243172A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113166783B (zh) | 2018-10-09 | 2024-10-11 | 不列颠哥伦比亚大学 | 包含无有机溶剂和去污剂的转染活性囊泡的组合物和系统以及与之相关的方法 |
| AU2023259636A1 (en) * | 2022-04-29 | 2024-10-10 | Elevatebio Technologies, Inc. | Production of rna polynucleotides encoding picornavirus |
| WO2023223183A1 (en) * | 2022-05-16 | 2023-11-23 | Crispr Therapeutics Ag | Picornaviral vectors for gene editing |
| EP4704872A2 (en) * | 2023-05-05 | 2026-03-11 | Mayo Foundation for Medical Education and Research | Methods and materials for treating cancer |
| WO2025072371A2 (en) * | 2023-09-27 | 2025-04-03 | The General Hospital Corporation | Highly active myeloid therapy |
| CN118460614B (zh) * | 2024-07-05 | 2025-03-11 | 凌意(杭州)生物科技有限公司 | 一种腺相关病毒Cap蛋白的表达框 |
| ES3058740A1 (es) * | 2025-08-01 | 2026-03-12 | Univ Valencia Politecnica | Nanopartícula lipídica, composición farmacéutica y uso de la nanopartícula en el tratamiento del cáncer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030040498A1 (en) * | 2001-03-14 | 2003-02-27 | Ansardi David Calvert | Oncolytic RNA replicons |
| US20030077251A1 (en) * | 2001-05-23 | 2003-04-24 | Nicolas Escriou | Replicons derived from positive strand RNA virus genomes useful for the production of heterologous proteins |
| US20100129406A1 (en) * | 2006-09-01 | 2010-05-27 | Anza Therapeutics, Inc. | Holin-enhanced vaccines and reagents, and methods of use thereof |
| JP6396891B2 (ja) * | 2013-04-17 | 2018-09-26 | 新日本製薬株式会社 | 遺伝子改変コクサッキーウイルス |
| MA41506A (fr) * | 2015-02-13 | 2017-12-19 | Takeda Vaccines Inc | Procédés de production de virus pour produire des vaccins |
| AU2018301701A1 (en) * | 2017-07-14 | 2020-02-27 | Elevatebio Technologies, Inc. | Encapsulated polynucleotides and methods of use |
| EP3876951A1 (en) * | 2018-11-06 | 2021-09-15 | Calidi Biotherapeutics, Inc. | Enhanced systems for cell-mediated oncolytic viral therapy |
-
2021
- 2021-05-28 US US17/999,582 patent/US20230416308A1/en active Pending
- 2021-05-28 CA CA3180557A patent/CA3180557A1/en active Pending
- 2021-05-28 WO PCT/US2021/034787 patent/WO2021243172A1/en not_active Ceased
- 2021-05-28 JP JP2022571787A patent/JP2023528300A/ja not_active Withdrawn
- 2021-05-28 KR KR1020227045616A patent/KR20230019450A/ko active Pending
- 2021-05-28 AU AU2021281357A patent/AU2021281357A1/en not_active Abandoned
- 2021-05-28 EP EP21812110.1A patent/EP4157456A4/en not_active Withdrawn
- 2021-05-28 CN CN202180038250.2A patent/CN115666722A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7776176B2 (ja) | 環状rnaを調製するための構築物及び方法 | |
| EP4141111A1 (en) | Oncolytic virus vaccine and drug for treating tumors by combining oncolytic virus vaccine with immune cells | |
| JP2004525855A5 (https=) | ||
| JPWO2020142725A5 (https=) | ||
| Zhao et al. | Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy | |
| JP2003511080A (ja) | 免疫治療組成物調製用のレンチウイルスベクター | |
| JPWO2019226941A5 (https=) | ||
| Kairuz et al. | Advancing mRNA technologies for therapies and vaccines: An African context | |
| CN118414426A (zh) | 产生环状rna的单罐法 | |
| CN118556131A (zh) | 用于蛋白质表达的mRNA及其模板 | |
| JP2005508610A (ja) | 異種タンパク質の製造に有用なプラス鎖rnaウイルスゲノムに由来するレプリコン | |
| JPWO2021243172A5 (https=) | ||
| EP4333892A1 (en) | Chimeric antigen receptors and methods of use | |
| JPWO2022150485A5 (https=) | ||
| FR2559159A1 (fr) | Vecteurs viraux de clonage et d'expression d'une proteine dans une cellule eucaryote, comportant au moins une partie du genome d'un retro-virus; cellules eucaryotes transfectees; procede utilisant de telles cellules et proteines obtenues | |
| JP2022536945A (ja) | B型肝炎ウイルス(HBV)ワクチンおよびHBVを標的化するRNAiの組合せ | |
| US20060088536A1 (en) | Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles | |
| JP2024503000A (ja) | 発現構築物およびその使用 | |
| KR100686356B1 (ko) | 중공 나노입자를 형성하는 단백질에 질환 치료용 세포도입 물질을 융합시킨 약제 | |
| JPWO2019158955A5 (https=) | ||
| EP4326879A2 (en) | Drug-regulatable transcription factors | |
| WO2025016031A1 (zh) | 自扩增核酸分子及其应用 | |
| US20230272423A1 (en) | Dna molecules producing custom designed replicating and non-replicating negative stranded rna viruses and uses there of | |
| JPWO2021003348A5 (https=) | ||
| CA3255274A1 (en) | Lipid nanoparticles including a Venezuelan equine encephalitis (VEE) replica and their uses |